NCS Testing Technology Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
NCS Testing Technology has a total shareholder equity of CN¥1.1B and total debt of CN¥15.1M, which brings its debt-to-equity ratio to 1.3%. Its total assets and total liabilities are CN¥1.9B and CN¥769.3M respectively. NCS Testing Technology's EBIT is CN¥90.0M making its interest coverage ratio 22.8. It has cash and short-term investments of CN¥99.4M.
Belangrijke informatie
1.3%
Verhouding schuld/eigen vermogen
CN¥15.05m
Schuld
| Rente dekkingsratio | 22.8x |
| Contant | CN¥99.38m |
| Aandelen | CN¥1.13b |
| Totaal verplichtingen | CN¥769.26m |
| Totaal activa | CN¥1.90b |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
NCS Testing Technology's (SZSE:300797) Profits May Not Reveal Underlying Issues
Nov 01
Subdued Growth No Barrier To NCS Testing Technology Co., Ltd. (SZSE:300797) With Shares Advancing 30%
Sep 28There's Reason For Concern Over NCS Testing Technology Co., Ltd.'s (SZSE:300797) Massive 30% Price Jump
Sep 27NCS Testing Technology Co., Ltd.'s (SZSE:300797) Price Is Out Of Tune With Earnings
Jun 07Concerns Surrounding NCS Testing Technology's (SZSE:300797) Performance
May 01NCS Testing Technology Co., Ltd.'s (SZSE:300797) Business Is Trailing The Market But Its Shares Aren't
Feb 27Analyse van de financiële positie
Kortlopende schulden: 300797's short term assets (CN¥987.9M) exceed its short term liabilities (CN¥521.5M).
Langlopende schulden: 300797's short term assets (CN¥987.9M) exceed its long term liabilities (CN¥247.7M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 300797 has more cash than its total debt.
Schuld verminderen: 300797's debt to equity ratio has increased from 0% to 1.3% over the past 5 years.
Schuldendekking: 300797's debt is well covered by operating cash flow (686.8%).
Rentedekking: 300797's interest payments on its debt are well covered by EBIT (22.8x coverage).